Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72632 record(s)

Req # A-2020-000719

Adverse Reaction Reports (AERs) for Mesalazine. Report numbers: E2B_03034109, E2B_03034115, E2B_03034116, E2B_03034117, E2B_03034118, E2B_03034122, E2B_03035579, 000910919, E2B_03054315, E2B_03054673, E2B_03072859, E2B_03074626, E2B_03074952,…

Organization: Health Canada

199 page(s)
November 2020

Req # A-2020-000720

Adverse Reaction Reports (AERs) for Mesalazine. Report numbers: E2B_03143352, E2B_03149455, E2B_03154815, E2B_03166561, E2B_03166583, E2B_03169169 , E2B_03169172 , E2B_03170001. AER for Antihemophilic factor (recombinant). Report number:…

Organization: Health Canada

86 page(s)
November 2020

Req # A-2020-000728

Adverse Reaction Report (AER) for IXAZOMIB. Report number: E2B_03196983. AERs for ONDANSETRON. Report numbers: 000916283, E2B_03212229, E2B_03215055, E2B_03218309. AERs for PANTOPRAZOLE. Report numbers: E2B_03174989, E2B_03196072, E2B_03200014,…

Organization: Health Canada

449 page(s)
November 2020

Req # A-2020-000752

Adverse Reaction Report (AER) for Botulinum toxin. Report number: E2B_03182645.

Organization: Health Canada

6 page(s)
November 2020

Req # A-2020-000754

Adverse Reaction Report (AER) for Botulinum toxin. Report number: E2B_03202605.

Organization: Health Canada

8 page(s)
November 2020

Req # A-2020-000755

Adverse Reaction Report (AER) for Botulinum toxin. Report number: E2B_03213260.

Organization: Health Canada

10 page(s)
November 2020

Req # A-2020-000815

Adverse Reaction Report (AER) for Botulinum toxin. Report number: E2B_03103217.

Organization: Health Canada

8 page(s)
November 2020

Req # A-2020-000818

Adverse Reaction Report (AER) for Botulinum toxin. Report number: E2B_03232927.

Organization: Health Canada

10 page(s)
November 2020

Req # A-2020-000819

Adverse Reaction Report (AER) for Botulinum toxin. Report number: E2B_03245899.

Organization: Health Canada

8 page(s)
November 2020

Req # A-2020-000821

Adverse Reaction Report (AER) for Botulinum toxin. Report number: E2B_03240059.

Organization: Health Canada

10 page(s)
November 2020
Date modified: